The following guideline can be ordered through the address listed in the "Source/Publisher"-category. In cases in which you can order through the Internet we have established a hyperlink.

FDA Guidance for Industry: Drug Supply Chain Security Act Implementation: Identification of Suspect Product and Notification



This guidance is intended to aid trading partners3 (manufacturers, repackagers, wholesale distributors, or dispensers) in identifying a suspect product and terminating notifications regarding illegitimate product

Go back

GMP Conferences by Topics